U.S. Markets closed

Shire plc (SHPG)

YHD - YHD Delayed Price. Currency in USD
Add to watchlist
At close: 6:07PM EDT
Full screen
Previous CloseN/A
YTD ReturnN/A
Expense Ratio (net)N/A
Last Cap GainN/A
Morningstar RatingN/A
Morningstar Risk RatingN/A
Sustainability RatingN/A
Net AssetsN/A
Beta (5Y Monthly)N/A
5y Average ReturnN/A
Holdings TurnoverN/A
Last DividendN/A
Average for CategoryN/A
Inception DateN/A
  • Moody's

    Shire Acq Inv Ireland Designated Activity Co -- Moody's affirms Takeda's ratings; assigns Baa2 to proposed notes

    Moody's Japan K.K. has affirmed the Baa2 long-term issuer and senior unsecured ratings of Takeda Pharmaceutical Company Limited (Takeda) and its subsidiaries, and assigned (P)Baa2 foreign currency senior unsecured rating to shelf registration of Takeda and Baa2 ratings to its proposed senior unsecured notes. "The affirmation of Takeda's Baa2 ratings reflects its being on track to deleveraging as expected following its transformative Shire acquisition," says Yukiko Asanuma, a Moody's Analyst. In the year and a half following the JPY6 trillion acquisition of Shire plc, Takeda increased sales of its key drugs and divested non-core assets, and has used free cash flow to pay down JPY657 billion of debt, which is down 11% from just following the acquisition in fiscal 2018 ended March 2019.

  • Moody's

    Shire Acq Inv Ireland Designated Activity Co -- Moody's announces completion of a periodic review of ratings of Takeda Pharmaceutical Company Limited

    Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Takeda Pharmaceutical Company Limited and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers. This publication does not announce a credit rating action and is not an indication of whether or not a credit rating action is likely in the near future.